Logo image of NRM.CA

NORAM LITHIUM CORP (NRM.CA) Stock Fundamental Analysis

TSX-V:NRM - TSX Venture Exchange - CA65542K1030 - Common Stock - Currency: CAD

0.095  0 (0%)

Fundamental Rating

0

Overall NRM gets a fundamental rating of 0 out of 10. We evaluated NRM against 797 industry peers in the Metals & Mining industry. Both the profitability and financial health of NRM have multiple concerns. NRM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NRM has reported negative net income.
NRM had a negative operating cash flow in the past year.
In the past 5 years NRM always reported negative net income.
NRM had a negative operating cash flow in each of the past 5 years.
NRM.CA Yearly Net Income VS EBIT VS OCF VS FCFNRM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2M -4M -6M -8M

1.2 Ratios

With a Return On Assets value of -53.03%, NRM is not doing good in the industry: 64.99% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -59.83%, NRM is in line with its industry, outperforming 42.03% of the companies in the same industry.
Industry RankSector Rank
ROA -53.03%
ROE -59.83%
ROIC N/A
ROA(3y)-50.07%
ROA(5y)-67.78%
ROE(3y)-53.46%
ROE(5y)-73.08%
ROIC(3y)N/A
ROIC(5y)N/A
NRM.CA Yearly ROA, ROE, ROICNRM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NRM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NRM.CA Yearly Profit, Operating, Gross MarginsNRM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for NRM has been increased compared to 1 year ago.
NRM has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NRM is higher compared to a year ago.
NRM.CA Yearly Shares OutstandingNRM.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
NRM.CA Yearly Total Debt VS Total AssetsNRM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M

2.2 Solvency

NRM has an Altman-Z score of 0.20. This is a bad value and indicates that NRM is not financially healthy and even has some risk of bankruptcy.
NRM has a Altman-Z score (0.20) which is in line with its industry peers.
NRM has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of NRM (0.02) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 0.2
ROIC/WACCN/A
WACCN/A
NRM.CA Yearly LT Debt VS Equity VS FCFNRM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 0.91 indicates that NRM may have some problems paying its short term obligations.
The Current ratio of NRM (0.91) is comparable to the rest of the industry.
NRM has a Quick Ratio of 0.91. This is a bad value and indicates that NRM is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of NRM (0.91) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.91
NRM.CA Yearly Current Assets VS Current LiabilitesNRM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

NRM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.65%, which is quite impressive.
EPS 1Y (TTM)40.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.87%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NRM. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NRM.CA Price Earnings VS Forward Price EarningsNRM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NRM.CA Per share dataNRM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NRM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NORAM LITHIUM CORP

TSX-V:NRM (8/5/2025, 7:00:00 PM)

0.095

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)06-30 2025-06-30
Earnings (Next)09-29 2025-09-29
Inst Owners5.8%
Inst Owner ChangeN/A
Ins Owners8.42%
Ins Owner ChangeN/A
Market Cap8.50M
Analysts84.44
Price Target1.16 (1121.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.57
P/tB 1.57
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.06
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -53.03%
ROE -59.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-50.07%
ROA(5y)-67.78%
ROE(3y)-53.46%
ROE(5y)-73.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 767.51%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.91
Altman-Z 0.2
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)3838.09%
Cap/Depr(5y)2641.43%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.87%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y46.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.41%
OCF growth 3YN/A
OCF growth 5YN/A